MA45272A - Produits issus de liquide amniotique et procédés d'utilisation - Google Patents

Produits issus de liquide amniotique et procédés d'utilisation

Info

Publication number
MA45272A
MA45272A MA045272A MA45272A MA45272A MA 45272 A MA45272 A MA 45272A MA 045272 A MA045272 A MA 045272A MA 45272 A MA45272 A MA 45272A MA 45272 A MA45272 A MA 45272A
Authority
MA
Morocco
Prior art keywords
methods
amniotic fluid
fluid products
products
amniotic
Prior art date
Application number
MA045272A
Other languages
English (en)
Inventor
Richard A Berg
John Daniel
Sarah Griffiths
Original Assignee
Stimlabs Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stimlabs Llc filed Critical Stimlabs Llc
Publication of MA45272A publication Critical patent/MA45272A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Microbiology (AREA)
MA045272A 2015-06-27 2016-06-27 Produits issus de liquide amniotique et procédés d'utilisation MA45272A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562185605P 2015-06-27 2015-06-27

Publications (1)

Publication Number Publication Date
MA45272A true MA45272A (fr) 2018-05-02

Family

ID=56404318

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045272A MA45272A (fr) 2015-06-27 2016-06-27 Produits issus de liquide amniotique et procédés d'utilisation

Country Status (4)

Country Link
US (2) US11559553B2 (fr)
EP (1) EP3313986A1 (fr)
MA (1) MA45272A (fr)
WO (1) WO2017003954A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
US10960027B2 (en) 2016-03-23 2021-03-30 Mimedx Group, Inc. Compositions and methods of treatment with amniotic fluid
JP6373444B1 (ja) * 2017-05-10 2018-08-15 株式会社ホルス 羊膜由来原料の製造方法、化粧品の製造方法及び健康食品の製造方法
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
US11154641B2 (en) 2017-12-22 2021-10-26 Stimlabs Llc Translucent, dehydrated placental tissue and methods of producing and using the same
CN108379094B (zh) * 2018-04-24 2021-09-14 广州暨南大学医药生物技术研究开发中心有限公司 包含生物活性美容多肽脂质立方晶的组合物及其在化妆品中的应用
WO2020176801A1 (fr) 2019-02-28 2020-09-03 Fagg William Samuel Iv Vésicules extracellulaires dérivées de liquide amniotique et leurs utilisations pour la cicatrisation de plaies
CN110223246B (zh) * 2019-05-17 2021-05-18 杭州趣维科技有限公司 一种多风格人像美颜磨皮方法及装置
TR201917367A1 (tr) * 2019-11-08 2021-05-21 Acibadem Labmed Saglik Hizmetleri A S Saç dökülmesi̇ ve skar tedavi̇si̇nde kullanima uygun bi̇r ürünün üreti̇mi̇ i̇çi̇n bi̇r yöntem
US12377121B2 (en) 2020-04-10 2025-08-05 Zeo Scientifix, Inc. Compositions comprising nanoparticles, method of making and uses thereof
US12213994B2 (en) 2021-12-08 2025-02-04 Zeo Scientifix, Inc. Compositions and methods for treating pain with extracellular vesicles
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001944A (en) 1975-08-25 1977-01-11 Parke, Davis & Company Freeze-drying process
US5494044A (en) * 1989-05-10 1996-02-27 Amnitec A/S Method for taking a sample of amniotic fluid
WO2003042405A2 (fr) * 2001-11-15 2003-05-22 Children's Medical Center Corporation Techniques d'isolation, de developpement et de differenciation de cellules souches provenant de villosites choriales, de liquide amniotique ainsi que de placenta et applications therapeutiques
AU2003272536A1 (en) 2002-09-18 2004-04-08 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
US7191068B2 (en) 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US7569385B2 (en) 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
EP1858533A4 (fr) 2005-02-22 2009-09-09 Univ Johns Hopkins Med Utilisation du fluide amniotique en traitement d'affections et de lesions oculaires
US8376984B2 (en) 2005-07-14 2013-02-19 Terry L. James Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin
US9057052B2 (en) 2005-10-21 2015-06-16 Kaneka Corporation Stem cell separating material and method of separation
KR101509139B1 (ko) * 2006-11-23 2015-04-08 주식회사 엘지생명과학 히알루론산의 정제방법
US20080227208A1 (en) * 2007-03-16 2008-09-18 Hsiao-Ching Yee Devices and Methods for Detection of Occult Blood
KR101078419B1 (ko) 2009-03-20 2011-10-31 주식회사 스템메디언스 양수 내 태아 유래 중간엽줄기세포를 이용한 피부 상태개선용 조성물
EP2679231A4 (fr) * 2011-02-25 2014-08-13 Kyungpook Nat Univ Hospital Agent pour le traitement de l'incontinence urinaire comprenant des cellules souches issues de liquide amniotique
US20120276215A1 (en) * 2011-04-26 2012-11-01 Riordan Neil H Therapeutic Conditioned Media
EP2717888B1 (fr) * 2011-06-10 2020-09-09 Tissuetech, Inc. Procédés de traitement de tissus foetaux de support
US20130136773A1 (en) * 2011-09-30 2013-05-30 NuTech Spine, Inc. Expandable Placental Membrane and Methods of Making and Storing Same
US20130218274A1 (en) 2011-12-02 2013-08-22 Mimedx Group, Inc. Shredded tissue grafts and methods for making and using the same
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
WO2014040026A2 (fr) 2012-09-10 2014-03-13 Wake Forest University Health Sciences Membrane amniotique et son utilisation dans des produits de construction de cicatrisation des plaies et d'ingénierie tissulaire
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
US10485521B2 (en) * 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
WO2014185945A1 (fr) 2013-05-13 2014-11-20 Cormatrix Cardiovascular, Inc. Compositions, méthodes et systèmes associés à des substances cosmétiques régénératives
US10449220B2 (en) * 2013-08-30 2019-10-22 Mimedx Group, Inc. Micronized placental compositions comprising a chelator
US20150140114A1 (en) 2013-11-19 2015-05-21 John R. SASKO Skin treatment protocol utilizing amniotic solution
TW201603818A (zh) * 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation

Also Published As

Publication number Publication date
US20180311283A1 (en) 2018-11-01
US11559553B2 (en) 2023-01-24
US20230126319A1 (en) 2023-04-27
WO2017003954A1 (fr) 2017-01-05
EP3313986A1 (fr) 2018-05-02

Similar Documents

Publication Publication Date Title
IL285767A (en) Product handling and packaging system
IL256369A (en) Novel crispr enzymes and systems
EP3359693A4 (fr) Procédés et compositions pour enrichissement de produits d'amplification
HUE054159T2 (hu) HPK1 gátlók és azok alkalmazási módja
HUE060129T2 (hu) Kezelõberendezés és eljárás munkadarabok kezeléséhez
EP3394065A4 (fr) Tétrahydropyranyl-amino-pyrrolopyrimidinone et procédés d'utilisation associés
EP3352774A4 (fr) Compositions de flavonoïdes et procédés d'utilisation
IL251390A0 (en) Polysaccharide and nucleic acid formulations that include viscosity-reducing agents
HUE055544T2 (hu) Kezelõberendezés és eljárás munkadarabok kezelésére
PL3253692T3 (pl) Urządzenie i sposób obsługi towarów
EP3303435A4 (fr) Hydrofluoroléfines et procédés d'utilisation associés
DK3265448T3 (da) Riluzol-prodrugs og anvendelse deraf
EP3319610A4 (fr) Oxystérols et leurs procédés d'utilisation
EP3368663A4 (fr) Lignées cellulaires exemptes de virus et procédés d'obtention de celles-ci
EP3319612A4 (fr) Oxystérols et leurs procédés d'utilisation
FI20155058A7 (fi) Partikkelimuotoinen polymeerituote ja sen käyttö
ITUB20160730A1 (it) Dispositivo per la movimentazione di manufatti
ITUB20155622A1 (it) Dispositivo e procedimento per la manipolazione di articoli come imballaggi multipli, collettami o simili
EP3380603A4 (fr) Procédés, milieux et produits pour la culture d'embryons
EP3289064A4 (fr) Compositions et procédés pour la détection d'allergènes
EP3302558A4 (fr) Agents anticancéreux et procédés d'utilisation
EP3370543A4 (fr) Produits d'insecte et leurs procédés de fabrication
EP3303436A4 (fr) Hydrofluorooléfines et leurs procédés d'utilisation
EP3393264A4 (fr) Produit laitier et procédés
EP3348661A4 (fr) Tôle d'acier et produit émaillé